Remove 2006 Remove Communication Remove Vaccines
article thumbnail

3 steps for comprehensive patient collaboration

pharmaphorum

He joined Johnson & Johnson in 2001 as Director Corporate Communications. In 2006 he joined the Janssen teams working in Infectious Diseases where he helped to maintain and enhance the company’s relationships with the HIV Patient Community. In that function, he initially worked in the field of oncology.

article thumbnail

In conversation with Regius Professor of Pharmacy Ian Wong

Hospital Pharmacy Europe

After finishing his degree here, he undertook his pre-registration in a busy community pharmacy in a deprived area of east London. One of the most valuable lessons he learnt from this experience was the importance of communication. ‘As Professor Wong is, unsurprisingly, very proud of this achievement. million residents of Hong Kong.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A history of Johnson & Johnson

pharmaphorum

The company has also faced claims that it did not adequately communicate the risks of its opioid painkillers in its marketing, contributing to the US’ ‘opioid epidemic’, and that its talc products could contain small amounts of asbestos and lead to cancer. In 2006, J&J acquired Pfizer Consumer Healthcare for $16.6 billion in cash.

Vaccines 126
article thumbnail

Methylprednisolone interactions to avoid

The Checkup by Singlecare

Other methylprednisolone interactions In those receiving high doses of corticosteroids, generally defined as systemic (as opposed to topical or inhaled) doses equivalent to more than 2 mg/kg or 20 mg/day of prednisone for more than two weeks, live vaccines should not be administered.

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

Nature Communications 12, no. Sanofi Pumps $554M into New Vaccine Manufacturing Facility in Eastern France.” www.fiercepharma.com/manufacturing/sanofi-pumps-554m-into-new-vaccine-manufacturing-facility-eastern-france 41 Boccard. New Project: Evolutive Vaccines Facility for Sanofi.” Biotechnology Progress 36, no.